These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33883876)
21. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623 [TBL] [Abstract][Full Text] [Related]
22. Comparison of transdermal versus oral estradiol on endometrial receptivity. Krasnow JS; Lessey BA; Naus G; Hall LL; Guzick DS; Berga SL Fertil Steril; 1996 Feb; 65(2):332-6. PubMed ID: 8566257 [TBL] [Abstract][Full Text] [Related]
23. Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone. Bergeron C; Ferenczy A Maturitas; 2001 Jan; 37(3):191-9. PubMed ID: 11173181 [TBL] [Abstract][Full Text] [Related]
24. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Check JH; Graziano V; Lee G; Nazari A; Choe JK; Dietterich C Clin Exp Obstet Gynecol; 2004; 31(2):99-102. PubMed ID: 15266759 [TBL] [Abstract][Full Text] [Related]
25. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients. Ozer G; Yuksel B; Yucel Cicek OS; Kahraman S J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102030. PubMed ID: 33271319 [TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate. Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759 [TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms. Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442 [TBL] [Abstract][Full Text] [Related]
28. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination. Taş M; Uludag SZ; Aygen ME; Sahin Y Gynecol Endocrinol; 2020 Jan; 36(1):77-80. PubMed ID: 31464143 [TBL] [Abstract][Full Text] [Related]
29. Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. O'Donnell RL; Warner P; Lee RJ; Walker J; Bath LE; Kelnar CJ; Wallace WH; Critchley HO Hum Reprod; 2012 Apr; 27(4):1130-8. PubMed ID: 22343553 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial. Karakus S; Kiran G; Ciralik H Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):685-8. PubMed ID: 20070724 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy of vaginal administration of Crinone versus Utrogestan combined with oral dydrogesterone tablets for luteal support in PGT freeze-thaw embryo transfer cycles]. Deng Y; Ou Z; Liang Y; Chen Z; Sun L Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1062-1066. PubMed ID: 34308857 [TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy. Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A; Rutanen EM Maturitas; 1995 Nov; 22(3):255-62. PubMed ID: 8746884 [TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels. Stangel-Wojcikiewicz K; Zdebik A; Jach R; Huras H; Wadowska-Jaszczynska K; Radon-Pokracka M; Kempisty-Zdebik E; Ludwin A; Ludwin I Neuro Endocrinol Lett; 2012; 33(7):697-702. PubMed ID: 23391877 [TBL] [Abstract][Full Text] [Related]
34. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457 [TBL] [Abstract][Full Text] [Related]
36. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial. Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239 [TBL] [Abstract][Full Text] [Related]
37. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study. Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464 [TBL] [Abstract][Full Text] [Related]
38. [Effect of estradiol supplementation during the luteal phase on mouse endometrial expression of leukaemia inhibitory factor and pinopodes in controlled ovarian stimulation cycles]. Zhang CL; Xie JK; Zhang SD; Qiao YH Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):937-41. PubMed ID: 19134335 [TBL] [Abstract][Full Text] [Related]
39. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136 [TBL] [Abstract][Full Text] [Related]
40. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles. Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]